Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes

Laryngoscope

Volumn 127, Issue 6, 2017, Pages 1451-1458

  Jowett, Nate ^a   Gaudin, Robert A ^a   Banks, Caroline A ^a   Hadlock, Tessa A ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Borrelia burgdorferi; Corticosteroids; facial nerve; facial palsy; facial paralysis; facial spasm; glucocorticoids; Lyme disease; nerve regeneration; neuroborreliosis; outcomes; prednisone; synkinesis

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VALACICLOVIR; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; BELL PALSY; CHILD; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DRUG USE; ERYTHEMA CHRONICUM MIGRANS; FACIAL NERVE PARALYSIS; FEMALE; HEADACHE; HERPES ZOSTER OTICUS; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYNKINESIS; TICK BITE; ADVERSE EFFECTS; COMBINATION DRUG THERAPY; COMPLICATION; EVALUATION STUDY; FACIAL PARALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CHILD; DRUG THERAPY, COMBINATION; FACIAL PARALYSIS; FEMALE; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84986277864     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.26273     Document Type: Article

References (45)

1. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet 2012;379:461–473.
2. Kuehn BM. CDC estimates 300,000 US cases of Lyme disease annually. JAMA 2013;310:1110.
3. Clark JR, Carlson RD, Sasaki CT, Pachner AR, Steere AC. Facial paralysis in Lyme disease. Laryngoscope 1985;95:1341–1345.
4. Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC. Evaluation of study patients with Lyme disease, 10–20-year follow-up. J Infect Dis 2001;183:453–460.
5. Halperin JJ. Nervous system Lyme disease. Infect Dis Clin North Am 2015;29:241–253.
6. Jowett N, Hadlock TA. A contemporary approach to facial reanimation. JAMA Facial Plast Surg 2015;17:293–300. doi: 10.1001/jamafacial.2015.0399.
7. Wetzig P. Aberrant regeneration of oculomotor and facial nerves. Rocky Mt Med J 1957;54:347–348.
8. Sumner AJ. Aberrant reinnervation. Muscle Nerve 1990;13:801–803.
9. Centers for Disease Control and Prevention. Lyme Disease (Borrelia burgdorferi) 2011 Case Definition. May 6, 2015. Available at: http://wwwn.cdc.gov/nndss/conditions/lyme-disease/case-definition/2011/. Accessed July 3, 2015 2015.
10. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089–1134.
11. Banks CA, Bhama PK, Park J, Hadlock CR, Hadlock TA. Clinician-graded electronic facial paralysis assessment: the eFACE. Plast Reconstr Surg 2015;136:223e–230e.
12. House JW. Facial nerve grading systems. Laryngoscope 1983;93:1056–1069.
13. Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007;69:91–102.
14. Treatment of Lyme disease. JAMA 2016;315:2461–2462.
15. Kanaya K, Ushio M, Kondo K, et al. Recovery of facial movement and facial synkinesis in Bell's palsy patients. Otol Neurotol 2009;30:640–644.
16. Schoen RT. A case revealing the natural history of untreated Lyme disease. Nat Rev Rheumatol 2011;7:179–184.
17. Halperin JJ, Golightly M. Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group. Neurology 1992;42:1268–1270.
18. de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA 2009;302:985–993.
19. Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg 2013;149:S1–S27.
20. Halperin JJ, Little BW, Coyle PK, Dattwyler RJ. Lyme disease: cause of a treatable peripheral neuropathy. Neurology 1987;37:1700–1706.
21. Molin S, Ruzicka T, Prinz JC. Bell's palsy during etanercept treatment caused by neuroborreliosis. Br J Dermatol 2010;163:228–230.
22. Centers for Disease Control and Prevention. Lyme Disease: Signs and Symptoms. Available at: http://www.cdc.gov/lyme/signs_symptoms/. Accessed June 19, 2015.
23. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996;124:27–30.
24. Liston SL, Kleid MS. Histopathology of Bell's palsy. Laryngoscope 1989;99:23–26.
25. Fisch U. Surgery for Bell's palsy. Arch Otolaryngol 1981;107:1–11.
26. Michaels L. Histopathological changes in the temporal bone in Bell's palsy. Acta Otolaryngol Suppl 1990;470:114–117; discussion 118.
27. Duray PH. Clinical pathologic correlations of Lyme disease. Rev Infect Dis 1989;11(suppl 6):S1487–S1493.
28. Meier C, Grahmann F, Engelhardt A, Dumas M. Peripheral nerve disorders in Lyme-Borreliosis. Nerve biopsy studies from eight cases. Acta Neuropathol 1989;79:271–278.
29. Bai Y, Narayan K, Dail D, et al. Spinal cord involvement in the nonhuman primate model of Lyme disease. Lab Invest 2004;84:160–172.
30. Sigal LH, Williams S, Soltys B, Gupta R. H9724, a monoclonal antibody to Borrelia burgdorferi's flagellin, binds to heat shock protein 60 (HSP60) within live neuroblastoma cells: a potential role for HSP60 in peptide hormone signaling and in an autoimmune pathogenesis of the neuropathy of Lyme disease. Cell Mol Neurobiol 2001;21:477–495.
31. England JD, Bohm RP Jr, Roberts ED, Philipp MT. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol 1997;41:375–384.
32. Gilchrist JM. AAEM case report #26: seventh cranial neuropathy. Muscle Nerve 1993;16:447–452.
33. Kristoferitsch W, Sluga E, Graf M, et al. Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features. Ann N Y Acad Sci 1988;539:35–45.
34. Vallat JM, Hugon J, Lubeau M, Leboutet MJ, Dumas M, Desproges-Gotteron R. Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology 1987;37:749–753.
35. Kindstrand E, Nilsson BY, Hovmark A, et al. Polyneuropathy in late Lyme borreliosis: a clinical, neurophysiological and morphological description. Acta Neurol Scand 2000;101:47–52.
36. Elamin M, Alderazi Y, Mullins G, Farrell MA, O'Connell S, Counihan TJ. Perineuritis in acute lyme neuroborreliosis. Muscle Nerve 2009;39:851–854.
37. Sigal LH. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein. J Infect Dis 1993;167:1372–1378.
38. Sigal LH, Tatum AH. Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology 1988;38:1439–1442.
39. Garcia Monco JC, Wheeler CM, Benach JL, et al. Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides. J Neurol Sci 1993;117:206–214.
40. Garcia-Monco JC, Seidman RJ, Benach JL. Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides. Infect Immun 1995;63:4130–4137.
41. Halperin J, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain 1990;113:1207–1221.
42. Hughes RA, van Der Meche FG. Corticosteroids for treating Guillain-Barre syndrome. Cochrane Database Syst Rev 2000:CD001446.
43. Hughes RA. Ineffectiveness of high-dose intravenous methylprednisolone in Guillain-Barre syndrome. Lancet 1991;338:1142.
44. Double-blind trial of intravenous methylprednisolone in Guillain-Barre syndrome. Guillain-Barre Syndrome Steroid Trial Group. Lancet 1993;341:586–590.
45. Pachner AR, Amemiya K, Bartlett M, Schaefer H, Reddy K, Zhang WF. Lyme borreliosis in rhesus macaques: effects of corticosteroids on spirochetal load and isotype switching of anti-Borrelia burgdorferi antibody. Clin Diagn Lab Immunol 2001;8:225–232.